Concepedia

Author

Jeff Hutchins

Research Triangle Park Foundation

Also Known As

Jeff Hutchins, Jeff T Hutchins, Jeff T. Hutchins, McSweeney, Morgan D

84

Publications

1.6K

Citations

21

H-Index

46

Concepts

All Affiliations

Research Triangle Park FoundationSenex Biotechnology (United States)Avid Bioservices (United States)Cardiff UniversityGlaxoSmithKline (United States)
JH

About

Jeff Hutchins is an author at Research Triangle Park Foundation specializing in medicine, immunology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

503

2

Engineering

1

1

31

3

Health Sciences

1

1

73

4

Natural Sciences

1

1

52

5

Allergy

1

1

47

Jeff Hutchins

×

25

Publications

1.5K

Citations

21

H-Index

YearCitations

Inhibition of colony-stimulating-factor-1 signaling<i>in vivo</i>with the orally bioavailable cFMS kinase inhibitor GW2580

James G. Conway, Brad McDonald, Janet H. Parham,

Proceedings of the National Academy of Sciences

2005

252

Characterization of a Protective Monoclonal AntibodyRecognizing <i>Staphylococcus aureus</i> MSCRAMM ProteinClumping FactorA

Andrea Hall, Paul Domanski, Pratiksha Patel,

Infection and Immunity

2003

144

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression

Canan Kasikara, Sushil Kumar, Stanley Kimani,

Molecular Cancer Research

2017

122

Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus

Christopher McGuigan, Karolina Madela, Mohamed Aljarah,

Bioorganic & Medicinal Chemistry Letters

2010

99

INX-08189, a Phosphoramidate Prodrug of 6-<i>O</i>-Methyl-2′-<i>C</i>-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties

John Vernachio, Blair Bleiman, K. Dawn Bryant,

Antimicrobial Agents and Chemotherapy

2011

84

Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers

Michael J. Gray, Jian Gong, Michaela M.S. Hatch,

Breast Cancer Research

2016

74

Characterization of a Humanized Monoclonal Antibody Recognizing Clumping Factor A Expressed by <i>Staphylococcus aureus</i>

Paul Domanski, Pratiksha Patel, Arnold S. Bayer,

Infection and Immunity

2005

73

Site-specific Conjugation on Serine → Cysteine Variant Monoclonal Antibodies

Julie B. Stimmel, B M Merrill, Lee F. Kuyper,

Journal of Biological Chemistry

2000

70

Monoclonal antibodies specific for Candida albicans Als3 that immunolabel fungal cells in vitro and in vivo and block adhesion to host surfaces

D. A. Coleman, Soon-Hwan Oh, Xiaomin Zhao,

Journal of Microbiological Methods

2009

69

Production of monoclonal antibodies using recombinant baculovirus displaying gp64–fusion proteins

Kathryn M. Lindley, Jui‐Lan Su, Paula K. Hodges,

Journal of Immunological Methods

2000

63

Page 1